Preventing Professional & Duplicate Participants from Entering GLP-1 Clinical Trials: It’s Not A Matter of If there will be Duplicates. Rather, How Many…
Time: 11:20 am
day: Day Two
Details:
- Enhancing Patient Safety, Data Quality, and Study Integrity
- Current trends we are seeing within the GLP-1 space related to duplicate & professional participants and ways to mitigate this risk
- Why do participants dual enroll? The "participant personas" identified by Verified Clinical Trials
- How prevention of professional & duplicate participants (vs detection) can save time and money, reduce dropout rates, can reduce placebo response / strengthen efficacy, and make you more competitive
